Candidate gene region 2q33 in European families with coeliac disease

Tissue Antigens

Volumn 63, Issue 3, 2004, Pages 212-222

  Holopainen, P ^a,h   Naluai, A T ^b   Moodie, S ^c   Percopo, S ^d   Coto, I ^d   Clot, F ^e   Ascher, H ^f   Sollid, L ^g   Ciclitira, P ^c   Greco, L ^d   Clerget Darpoux, F ^e   Partanen, J ^a  

^a Thermo Fisher Scientific Oy   (Finland)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e INSERM   (France)

^f QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^g OSLO UNIVERSITY HOSPITAL   (Norway)

^h SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

Author keywords

Autoimmunity; Coeliac disease; CTLA 4; Genetic susceptibility; T lymphocytes

Indexed keywords

CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ALLELE; ARTICLE; CELIAC DISEASE; CHROMOSOME 2Q; CONTROLLED STUDY; DISEASE PREDISPOSITION; EUROPE; FEMALE; GENE CLUSTER; GENE LOCUS; GENETIC LINKAGE; GENETIC MARKER; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ALLELES; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTIGENS, SURFACE; APOPTOSIS REGULATORY PROTEINS; CELIAC DISEASE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 2; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE (GENETICS); MALE; POLYMORPHISM, GENETIC;

EID: 10744232344     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2004.00189.x     Document Type: Article

References (45)

1. Mäki M, Collin P. Coeliac disease. Lancet 1997: 349: 1755-9.
2. Sollid LM. Molecular basis of celiac disease. Annu Rev Immunol 2000: 18: 53-81.
3. Karell K, Louka AS, Moodie SJ, Ascher H, Clot F, Greco L et a. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol 2003: 64: 469-77.
4. Rotter JI, Landaw EM. Measuring the genetic contribution of a single locus to a multilocus disease. Clin Genet 1984: 26: 529-42.
5. Risch N. Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet 1987: 40: 1-14.
6. Petronzelli F, Bonamico M, Ferrante P, Grillo R, Mora B, Mariani P et al. Genetic contribution of the HLA region to the familial clustering of coeliac disease. Ann Hum Genet 1997: 61: 307-17.
7. Bevan S, Popat S, Braegger CP, Busch A, O'Donoghue D, Falth-Magnusson K et al. Contribution of the MHC region to the familial risk of coeliac disease. J Med Genet 1999: 36: 687-90.
8. Zhong F, McCombs CC, Olson JM, Elston RC, Stevens FM, McCarthy CF et al. An autosomal screen for genes that predispose to celiac disease in the western counties of Ireland. Nat Genet 1996: 14: 329-33.
9. Greco L, Corazza G, Babron MC, Clot F, Fulchignoni-Lataud MC, Percopo S et al. Genome search in celiac disease. Am J Hum Genet 1998: 62: 669-75.
10. King AL, Yiannakou JY, Brett PM, Curtis D, Morris MA, Dearlove AM et al. A genome-wide family-based linkage study of coeliac disease. Ann Hum Genet 2000: 64: 479-90.
11. Naluai TA, Nilsson S, Gudjonsdottir AH, Louka AS, Ascher H, Ek J et al. Genome-wide linkage analysis of Scandinavian affected sibpairs supports presence of susceptibility loci for celiac disease on chromosomes 5 and 11. Eur J Hum Genet 2001: 9: 938-44.
12. Liu J, Juo SH, Holopainen P, Terwilliger J, Tong X, Grunn A et al. Genomewide linkage analysis of celiac disease in Finnish families. Am J Hum Genet 2002: 70: 51-9.
13. Popat S, Bevan S, Braegger CP, Busch A, O'Donoghue D, Falth-Magnusson K et al. Genome screening of coeliac disease. J Med Genet 2002: 39: 328-31.
14. Woolley N, Holopainen P, Ollikainen V, Mustalahti K, Mäki M, Kere J et al. A new locus for coeliac disease mapped to chromosome 15 in a population isolate. Hum Genet 2002: 111: 40-5.
15. Neuhausen SL, Feolo M, Camp NJ, Farnham J, Book L, Zone JJ. Genome-wide linkage analysis for celiac disease in North American families. Am J Med Genet 2002: 111: 1-9.
16. Ling V, Wu PW, Finnerty HF, Agostino MJ, Graham JR, Chen S et al. Assembly and annotation of human chromosome 2q33 sequence containing the CD28, CTLA4, and ICOS gene cluster analysis by computational, comparative, and microarray approaches. Genomics 2001: 78: 155-68.
17. Allison JP, Krummel MF. The Yin and Yang of T cell costimulation. Science 1995: 270: 932-3.
18. Liang L, Sha WC. The right place at the right time: novel B7 family members regulate effector T cell responses. Curr Opin Immunol 2002: 14: 384-90.
19. Kristiansen OP, Larsen ZM, Pociot F. CTLA-4 in autoimmune diseases - a general susceptibility gene to autoimmunity? Genes Immun 2000: 1: 70-84.
20. Ligers A, Teleshova N, Masterman T, Huang WX, Hillert J. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2001: 2: 145-52.
21. Wang ZB, Zhao X, Giscombe R, Lefvert AK. A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of protein. Genes Immun 2002: 3: 233-4.
22. Mäurer M, Loserth S, Kolb-Mäurer A, Ponath A, Wiese S, Kruse N et al. A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation. Immunogenetics 2002: 54: 1-8.
23. Anjos S, Nguyen A, Ounissi-Benkalha H, Tessier MC, Polychronakos C. A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J Biol Chem 2002: 277: 46478-86.
24. Huang D, Giscombe R, Zhou Y, Pirskanen R, Lefvert AK. Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyperreactivity via the CD28 pathway in myasthenia gravis. J Neuroimmunol 2000: 105: 69-77.
25. Holopainen PM, Partanen JA. Technical note: linkage disequilibrium and disease-associated CTLA4 gene polymorphisms. J Immunol 2001: 167: 2457-8.
26. Ueda H, Howson J, Esposito L, Heward J, Snook H, Chamberlain G et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003: 423: 506-11.
27. Djilali-Saiah I, Schmitz J, Harfouch-Hammoud E, Mougenot J-F, Bach J-F, Caillat-Zucman S. CTLA-4 gene polymorphism is associated with predisposition to coeliac disease. Gut 1998: 43: 187-9.
28. Holopainen P, Arvas M, Sistonen P, Mustalahti K, Collin P, Mäki M et al. CD28/CTLA4 gene region on chromosome 2q33 confers genetic susceptibility to celiac disease. A linkage and family-based association study. Tissue Antigens 1999: 53: 470-5.
29. Torinsson Naluai Å, Nilsson S, Samuelsson L, Gudjonsdottir AH, Ascher H, Ek J et al. The CTLA4/CD28 gene region on chromosome 2q33 confers susceptibility to celiac disease in a way possibly distinct from that of type 1 diabetes and other chronic inflammatory disorders. Tissue Antigens 2000: 56: 350-5.
30. King AL, Moodie SJ, Fraser JS, Curtis D, Reid E, Dearlove AM et al. CTLA-4/CD28 gene region is associated with genetic susceptibility to coeliac disease in UK families. J Med Genet 2002: 39: 51-4.
31. Popat S, Hearle N, Wixey J, Hogberg L, Bevan S, Lim W et al. Analysis of the CTLA4 gene in Swedish coeliac disease patients. Scand J Gastroenterol 2002: 37: 28-31.
32. Mora B, Bonamico M, Indovina P, Megiorni F, Ferri M, Carbone MC et al. CTLA-4 + 49 A/G dimorphism in Italian patients with celiac disease. Hum Immunol 2003: 64: 297-301.
33. Popat S, Hearle N, Hogberg L, Braegger CP, O'Donoghue D, Falth-Magnusson K et al. Variation in the CTLA4/CD28 gene region confers an increased risk of coeliac disease. Ann Hum Genet 2002: 66: 125-37.
34. Clot F, Fulchignoni-Lataud MC, Renoux C, Percopo S, Bouguerra F, Babron MC et al. Linkage and association study of the CTLA-4 region in coeliac disease for Italian and Tunisian populations. Tissue Antigens 1999: 54: 527-30.
35. Neuhausen SL, Farnham J, Feolo M, Book L, Zone JJ. Linkage analysis of HLA and candidate genes for celiac disease in a North American family-based study. BMC Med Genet 2001: 2: 12.
36. Martin-Pagola A, Perez de Nanclares G, Vitoria JC, Bilbao JR, Ortiz L, Zubillaga P et al. No association of CTLA4 gene with celiac disease in the Basque population. J Pediatr Gastroenterol Nutr 2003: 37: 142-5.
37. Walker-Smith JA, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK. Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990: 65: 909-11.
38. Gudbjartsson DF, Jonasson K, Frigge ML, Kong A. Allegro, a new computer program for multipoint linkage analysis. Nat Genet 2000: 25: 12-3.
39. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996: 58: 1347-63.
40. Markianos K, Daly MJ, Kruglyak L. Efficient multipoint linkage analysis through reduction of inheritance space. Am J Hum Genet 2001: 68: 963-77.
41. Schneider S, Kueffer J-M, Roessli D, Excoffier L. Arlequin ver. 1.1: a software for population genetic data analysis. Genetics and Biometry Laboratory, University of Geneva, Switzerland 1997.
42. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium. The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993: 52: 506-16.
43. Johnson CG, Esposito L, Barratt BJ, Smith AN, Heward J, Di Genova G et al. Haplotype tagging for the identification of common disease genes. Nat Genet 2001: 29: 233-7.
44. Prokunina L, Castillejo-Lopez C, Oberg F, Gunnarsson I, Berg L, Magnusson V et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 2002: 32: 666-9.
45. Howard T, Postma DS, Koppelman GA, Koppelman GH, Zheng SL, Wysong AK et al. Fine mapping of an IgE-controlling gene on chromosome 2q: analysis of CTLA4 and CD28. J Allergy Clin Immunol 2002: 110: 743-51.